AB2 Bio Ltd., of Lausanne, Switzerland, appointed Michael Soldan CEO.
Addex Therapeutics Ltd., of Geneva, appointed Darryle D. Schoepp chair of its scientific advisory board.
Applied Therapeutics Inc., of New York, appointed Adam Hansard chief commercial officer.
Bluerock Therapeutics LLC, of Cambridge, Mass., appointed Seth Ettenberg chief scientific officer.
Oculis SA, of Lausanne, Switzerland, appointed Marcia de Souza Lima chief medical officer.
Rafael Pharmaceuticals Inc., of Cranbury, N.J., appointed Sanjay Sehgal chief regulatory affairs and quality assurance officer.
Sumitomo Dainippon Pharma Co. Ltd., of Osaka, Japan, appointed Shigeyuki Nishinaka senior executive officer; Koichi Kozuki, Isao Shimizu and Yumi Sato executive officers; and Nobuhiko Tamura representative director, president, Nihon MediPhysics Co. Ltd. All appointments are effective April 1, 2020.
Sutura Therapeutics Ltd., of Birkenhead, U.K., appointed James Noble and Eduardo Bravo to its board.